Makrolidy pri tyazheloy pnevmonii: pochemu i kak naznachat'?


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The article justifies the use of macrolide antibiotics, especially azithromycin, in the treatment of severe community-acquired pneumonia (CAP). The high efficiency of azithromycin in the treatment of Legionella CAP is demonstrated. It is emphasized that azithromycin as one of the drugs of parenteral combined antibacterial therapy is reasonably included in the national guideline for the treatment of patients with severe CAP. Even a long course of azithromycin is safe for patients with severe bacterial infection, and hepatocytolytic syndrome is transient with no signs of liver failure.

全文:

受限制的访问

参考

  1. Чучалин А.Г., Синопальников А.И., Козлов Р.С. и др. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике. Пособие для врачей. М., 2010. 82 с.
  2. Mandell LM, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis 2007;44(Suppl. 2):27-72.
  3. Guidelines for the management of adult lower respiratory tract infections/Guest Editor: Didier Raoult. Clin Microbiol Infect 2011;17 (Suppl. 6):1-Scorneaux B, Ouadrhiri Y, Anzalone G, et al. Intracellular activity of azithromycin in relation to its cellular disposition towards bacteria infecting distinct subcellular compartments. In: The 3rd International Conference on the Macrolides, Azalides and Streptogramins. Lisbon, 1996: abstr. 4.17. Odenholt-Tornqvist I, Lowdin E, Cars 0. Postantibiotic effects and postantibiotic subMIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens. Antimicrob Agents Chemother 1995;39:221-26.
  4. Fang GD, Stout JE, Yu VL. Comparison of intracellular postantibiotic effect of azithromycin and clarithromycin vs. erythromycin against Legionella pneumophila serogroup 1. In: The 36th International Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 1996; abstr. A91.
  5. Andes D. Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infectious. Curr Opin Infect Dis 2001;14:165-72.
  6. Plouffe J, Schwartz D, Kolokathis A, et al. Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. Antimicrob Agents Chemother 2000; 44(7): 1796-802.
  7. Wilton L, Kollarova M, Heeley E, Shakir S. Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England. Drug Saf 2003;26 (8):589-97.
  8. Culi O, Erakovi V, Cepelak I, et al. Azitromycin modulates neutrophil function and circulatig inflammatory mediators in healthy human subjects. Eur J Pharmacol 2002;450(3):277-89.
  9. Horney B, Ewig S, Tartakovskiy IS, et al. Legionellosis. Legionella and prevention of Legionellosis. WHO; 2007:1-27.
  10. Mandell LA, Wunderink RG, Anzueto A, et al. Clin Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Infect Dis 2007;44: S27-72.
  11. Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J 2002;36:20-7.
  12. Бобылева З.Д. Лещенко И.В., Клиническое течение легионеллезной пневмонии в период эпидемической вспышки легионеллеза в Свердловской области // Уральский медицинский журнал. 2009. №3. С. 123-33.
  13. Бобылева З.Д., Лещенко И.В. Клиниколабораторная характеристика легионеллезной пневмонии различной тяжести (по материалам эпидемической вспышки легионеллеза в Свердловской области) // Клиническая микробиология и антибактериальная химиотерапия. 2010. № 2(12). С. 117-26.
  14. Шерлок Ш. Заболевания печени и желчных путей (пер. с англ.). М., 1999. 386-423.
  15. DeLeve LD. Mechanisms of drug-induced liver disease. N Clin N Am 1995;24:787-810.
  16. Schiano TD. Drug-induced and toxic liver disease. Schiano TD, Black M. In: Friedman LS, Keefe EB, Maddrey WC (ed.). Handbook of Liver Disease. Churcill Livingstone 1998:103-23.
  17. Лещенко И.В., Кривоногов А.В. Особенности течения пневмонии при пандемическом гриппе A/H1N1/09 // Пульмонология. 2011. № 6. С. 62-8.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2012
##common.cookie##